Emergence Therapeutics
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
2
Funding Rounds
$191.3m
Money raised
Overview
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
- Website:
- Business model: B2B
- Headquarters: Duisburg
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Emergence Therapeutics has raised a total of $191.3m in funding over 2 rounds.
Key Insights:
- Emergence Therapeutics Series A round, December 2021: $92.3m
- Emergence Therapeutics December 2021 Funding Round: $99m
Emergence Therapeutics Series A round, December 2021
$92.3m
Emergence Therapeutics December 2021 Funding Round
$99m
Industries
Emergence Therapeutics is active in the following industries: